Clinical Studies

Ongoing Studies

NYX-2925

Phase 2 - Fibromyalgia (Exploratory)

A Single-Blind, Exploratory, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Daily Oral NYX-2925 in Subjects with Fibromyalgia — For more information, visit www.clinicaltrials.gov